1.
Finckh A, Kyburz D, Möller B, Schmiedel U, Villiger P, Walker U. Swiss Consensus Statement: Recommendations for optimising re-treatment with MabThera® (rituximab) in rheumatoid arthritis. Swiss Med Wkly [Internet]. 2010 Jul. 5 [cited 2024 Sep. 14];140(2728):w13073. Available from: https://smw.ch/index.php/smw/article/view/1150